Skip to main content
OpenTrials

Clinical trial condition

Penile Diseases

Explore clinical trials studying Penile Diseases. Study availability and eligibility vary by location and protocol.

204 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Penile Diseases trial results

Completed

Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer

NCT00066391

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • U.Z. Gasthuisberg Leuven, Belgium
  • Institut Gustave Roussy Villejuif, France
  • National Institute of Oncology Budapest, Hungary
  • Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands
View Trial Details
Completed

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00020579

Conditions
AIDS-related Kaposi sarcoma, Adenocarcinoma, Adenoma, +214 more
Locations
  • National Naval Medical Center Bethesda, Maryland, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • NCI - Center for Cancer Research Bethesda, Maryland, United States
View Trial Details
Completed

Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer

NCT00002506

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +46 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Bloomington Hospital Bloomington, Indiana, United States
  • St. Vincent Hospital and Health Care Center Indianapolis, Indiana, United States
  • Bergan Mercy Medical Center Omaha, Nebraska, United States
View Trial Details
Active, Not Recruiting

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

NCT03333616

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +28 more
Locations
  • University of California, San Diego Moores Cancer Center La Jolla, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

NCT04491942

Conditions
Adenoma, Adnexal Diseases, Advanced Bile Duct Carcinoma, +72 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
View Trial Details

Related conditions